Mark Danta is an Associate Professor of Medicine, UNSW and a Hepatologist, St Vincent’s Hospital, Sydney. He graduated from the University of Newcastle, NSW in 1992 and trained in Gastroenterology in Sydney. Developing an interest in liver disease and viral hepatitis he completed his clinical training in Hepatology at the Royal Free Hospital, London in 2001-2003. Following his clinical training he focused on research with a particular interest in viral hepatitis. He then completed his doctoral thesis on hepatitis C and HIV co-infection at the University College London in 2006. He returned to St Vincent’s Hospital, Sydney in 2007 as a Clinical Academic with the Faculty of Medicine, UNSW. He continues his research into viral hepatitis and advanced liver disease with independent funding and grants awarded from the National Health and Medical Research Council (NH&MRC). He is also a regular reviewer for a number of international peer reviewed journals. He has ongoing research collaborations with the Kirby Institute, Garvan Institute and Victor Chang, UNSW and Pharma trialing new therapies for viral hepatitis.